Skip to main content
SpringerLink
Log in

Effects of TJN-598, a new selective phosphodiesterase type IV inhibitor on anti-Thy1 nephritis in rats

  • Original Article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Background

Phosphodiesterase type IV (PDEIV) plays an important role in the immune response and inflammation. However, it is well known that classical PDEIV inhibitors have systemic side effects, so the clinical and chronic use of these agents as therapy for glomerulonephritis is difficult. This study was performed to elucidate the anti-nephritic effects of TJN-598, a new chemical compound derived from herbal components, on experimental mesangial proliferative glomerulonephritis.

Methods

We first examined the effects of TJN-598 and captopril on mesangial expansion induced by anti-Thy1 serum in rats. Second, to investigate the effects of TJN-598 and rolipram, which are typical PDEIV inhibitors, on the production of tumor necrosis factor (TNF)-α and transforming growth factor (TGF)-β1, glomeruli were isolated from rats with anti-Thy1 nephritis and incubated with the test drugs in vitro for 48 h.

Results

Treatment with TJN-598 prevented an increase in the mesangial area/total glomerular area, in the number of cells in the glomerular cross section and matrix index. TJN-598 also inhibited the increases in the expression of α-smooth muscle actin, the TGF-β1-positive area, in the number of ED-1 positive cells and proliferating cell nuclear antigen-positive cells in the glomeruli. Furthermore, administration of TJN-598 inhibited increases in the levels of TGF-β1 protein derived from glomeruli with anti-Thy-1 nephritis. The addition of both TJN-598 and rolipram to the culture supernatant inhibited both increased expression of TGF-β1 and increases in levels of TNF-α in glomeruli isolated from rats with anti-Thy1 nephritis in a dose-dependent manner.

Conclusion

These results suggest that TJN-598, a PDEIV inhibitor, is effective against expansion of mesangial cells, via the suppression of secretion of TGF-β1 and TNF-α from inflamed glomeruli.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Yu L, Border WA, Anderson I, McCourt M, Huang Y, Noble NA. Combining TGF-beta inhibition and angiotensin II blockade results in enhanced antifibrotic effect. Kidney Int. 2004;66:1774–84.

    Article  CAS  PubMed  Google Scholar 

  2. Martini S, Kramer S, Loof T, Wang-Rosenke Y, Daig U, Budde K, Neumayer HH, Peters H. SIP modulator FTY720 limits matrix expansion in acute anti-Thy1 mesangioproliferative glomerulonephritis. Am J Physiol Ren Physiol. 2007;292:F1761–70.

    Article  CAS  Google Scholar 

  3. Chao CC, Hu S, Sheng WS, Tsang M, Peterson PK. Tumor necrosis factor-alpha mediates the release of bioactive transforming growth factor-beta in murine microglial cell cultures. Clin Immunol Immunopathol. 1995;77:358–65.

    Article  CAS  PubMed  Google Scholar 

  4. Chini C, Grande JP, Chini EN, Dousa TP. Compartmentalization of cAMP signaling in mesangial cells by phosphodiesterase isozymes PDE3 and PDE4. Regulation of superoxidation and mitogenesis. J Biol Chem. 1997;272:9854–9.

    Article  CAS  PubMed  Google Scholar 

  5. Cheng J, Grande JP. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease. Exp Biol Med (Maywood). 2007;232:38–51.

    CAS  Google Scholar 

  6. Cheng J, Diaz Encarnacion MM, Warner GM, Gray CE, Nath KA, Grande JP. TGF-beta1 stimulates monocyte chemoattractant protein-1 expression in mesangial cells through a phosphodiesterase isoenzyme 4-dependent process. Am J Physiol Cell Physiol. 2005;289:C959–70.

    Article  CAS  PubMed  Google Scholar 

  7. Tam FW, Smith J, Agarwal S, Karkar AM, Morel D, Thompson EM, Pusey CD. Type IV phosphodiesterase inhibitor is effective in prevention and treatment of experimental crescentic glomerulonephritis. Nephron. 2000;84:58–66.

    Article  CAS  PubMed  Google Scholar 

  8. Tsuboi Y, Shankland SJ, Grande JP, Walker HJ, Johnson RJ, Dousa TP. Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes type III and IV. J Clin Invest. 1996;98:262–70.

    Article  CAS  PubMed  Google Scholar 

  9. Bertolino A, Crippa D, di Dio S, Fischte K, Musmeci G, Porro V, Rapisard V, Saster-y-Hernandez M, Schratzer M. Rolipram versus imipramine in inpatients with major, “minor” or atypical depressive disorder: a double-blind double-dummy study aimed at testing a novel therapeutic approach. Int Clin Psychopharmacol. 1988;3:245–53.

    Article  CAS  PubMed  Google Scholar 

  10. Hayashi K, Nagamatsu T, Ito M, Yagita H, Suzuki Y. Acteoside, a component of Stachys sieboldii MIQ, may be a promising antinephritic agent (3): effect of acteoside on expression of intercellular adhesion molecule-1 in experimental nephritic glomeruli in rats and cultured endothelial cells. Jpn J Pharmacol. 1996;70:157–68.

    Article  CAS  PubMed  Google Scholar 

  11. Hayashi K, Nagamatsu T, Ito M, Hattori T, Suzuki Y. Acteoside, a component of Stachys sieboldii MIQ, may be a promising antinephritic agent: effect of acteoside on crescentic-type anti-GBM nephritis in rats. Jpn J Pharmacol. 1994;65:143–51.

    Article  CAS  PubMed  Google Scholar 

  12. Hattori T, Fujitsuka N, Shindo S. Effect of acteoside on mesangial proliferation in rats anti-Thy1 nephritis. Nippon Jinzo Gakkai Shi. 1996;38:202–12.

    CAS  PubMed  Google Scholar 

  13. Tang SC, Leung JC, Chan LY, Eddy AA, Lai KN. Angiotensin converting enzyme inhibitor but not angiotensin receptor blockade or statin ameliorates murine adriamycin nephropathy. Kidney Int. 2008;73:288–99.

    Article  CAS  PubMed  Google Scholar 

  14. Hattori T, Sadakane C, Koseki J, Kase Y, Takeda S. Saireito probably prevents mesangial cell proliferation in HIGA mice via PDGF-BB tyrosine kinase inhibition. Clin Exp Nephrol. 2007;11:275–82.

    Article  CAS  PubMed  Google Scholar 

  15. Ballard SA, Gingell CJ, Tang K, Turner LA, Price ME, Naylor AM. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleoside phosphodiesterase isozymes. J Urol. 1998;159:2164–71.

    Article  CAS  PubMed  Google Scholar 

  16. Yoshimura A, Inui K, Nemoto T, Uda S, Sugenoya Y, Watanabe S, Yokota N, Taira T, Iwasaki S, Ideura T. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis. J Am Soc Nephrol. 1998;9:2027–39.

    CAS  PubMed  Google Scholar 

  17. Krammer S, Wang-Rosenke Y, Scholl V, Binder E, Loof T, Khadzhynov D, Kawachi H, Shimizu F, Diekman F, Budde K, Neumayer HH, Peters H. Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat. Am J Physiol Ren Physiol. 2008;294:F440–9.

    Article  Google Scholar 

  18. Lee TW, Ahn JH, Park JK, Ihm CG, Kim MJ. Effect of angiotensin converting enzyme inhibitor on collagen production by cultured mesangial cells. Korean J Intern Med. 1994;9:1–8.

    CAS  PubMed  Google Scholar 

  19. Peters H, Border WA, Noble NA. Targeting TGF-beta overexpression: maximizing the antifibrotic actions of angiotensin II blockade in anti-Thy1 glomerulonephritis. Nephrol Dial Transplant. 1999;14:22–3.

    Article  PubMed  Google Scholar 

  20. Aoki M, Fukunaga M, Sugimoto T, Hirano Y, Kobayashi M, Honda K, Yamada T. Studies on mechanisms of low emetogenicity of YM976, a novel phosphodiesterase type 4 inhibitor. J Pharmacol and Exp Ther. 2001;298:1142–9.

    CAS  Google Scholar 

  21. Whitman M. Smads and early developmental signaling by the TGF-beta superfamily. Genes Dev. 1998;12:2445–62.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tsumura Research Laboratories, Tsumura & Co., 3586 Yoshiwara, Ami-machi, Inashiki-gun, Ibaraki, Japan

    Chiharu Sadakane, Yoshio Kase, Junichi Koseki, Yoshihiro Hasegawa, Shoichiro Shindo, Hirobumi Maruyama, Shuichi Takeda & Tomohisa Hattori

  2. Division of Pharmasciences, Department of Pathophysiology and Therapeutics, Faculty of Pharmaceutical Sciences, Hokkaido University, N12 W6, Kita-ku, Sapporo, 060-0812, Japan

    Chiharu Sadakane & Hiroshi Takeda

Authors
  1. Chiharu Sadakane
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoshio Kase
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Junichi Koseki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoshihiro Hasegawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shoichiro Shindo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hirobumi Maruyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shuichi Takeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hiroshi Takeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Tomohisa Hattori
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tomohisa Hattori.

About this article

Cite this article

Sadakane, C., Kase, Y., Koseki, J. et al. Effects of TJN-598, a new selective phosphodiesterase type IV inhibitor on anti-Thy1 nephritis in rats. Clin Exp Nephrol 15, 14–24 (2011). https://doi.org/10.1007/s10157-010-0342-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-010-0342-8

Keywords

Search

Navigation